https://www.selleckchem.com/pr....oducts/bms-935177.ht
The specificity and NPV of the new patients group were significantly lower than those of the old patients group. Conclusion The DDW-J 2004 scale maintains a stable diagnostic ability for DILI, regardless of differences in eras and verification methods. However, differential diagnoses can affect the scoring, and new types of DILI, such as immune-related adverse events, must be addressed. Therefore, upgrading the scale should be considered.We encountered a case of ST-segment elevation myocardial infarction (STEMI) as the first clinical